Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
Withdrawn before enrolling · Phase 2
Conditions studied: Stage II Multiple Myeloma, Stage III Multiple Myeloma, Refractory Plasma Cell Neoplasm
In brief
RATIONALE: Drugs used in chemotherapy, such as melphalan, arsenic trioxide, and ascorbic acid, work in different ways to stop cancer cells from dividing so they stop growing or die. Arsenic trioxide and ascorbic acid may also help melphalan kill more cancer cells by making them more sensitive to the drugs. PURPOSE: This phase II trial is studying how well giving melphalan together with arsenic trioxide and ascorbic acid works in treating patients with relapsed or refractory multiple myeloma.
Key facts
- Study ID
- NCT00085345
- Run by
- Oncotherapeutics
- People needed
- 0
- Last updated by the study team
- 2013-07-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Palo Verde Hematology Oncology — Glendale, Arizona, United States
- Comprehensive Blood and Cancer Center — Bakersfield, California, United States
- Southbay Oncology / Hematology Medical Group — Campbell, California, United States
- Study site — Fountain Valley, California, United States
- Hematology-Oncology Medical Group of Fresno, Incorporated — Fresno, California, United States
- Hematology Oncology Medical Group of Orange County, Incorporated — Orange, California, United States
- Cancer Care Associates Medical Group - Redondo Beach — Redondo Beach, California, United States
- Redwood Regional Oncology Center - Sotoyome — Santa Rosa, California, United States
- Cancer Prevention and Treatment Center at Dominican and Watsonville Community Hospital — Soquel, California, United States
- San Diego Cancer Center - Vista — Vista, California, United States
- Oncotherapeutics — West Hollywood, California, United States
- Mount Sinai Comprehensive Cancer Center at Mount Sinai Medical Center — Miami Beach, Florida, United States
- Atlanta Cancer Care - Roswell — Roswell, Georgia, United States
- Tulane Cancer Center at Tulane University Hospital and Clinic — New Orleans, Louisiana, United States
- Center for Cancer and Blood Disorders at Suburban Hospital — Bethesda, Maryland, United States
- William Beaumont Hospital - Royal Oak Campus — Royal Oak, Michigan, United States
- Hackensack University Medical Center Cancer Center — Hackensack, New Jersey, United States
- Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Utah Cancer Specialists - Administrative Office — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.